» Articles » PMID: 16824135

Intrinsic Properties of Human and Murine Memory B Cells

Overview
Journal Immunol Rev
Date 2006 Jul 11
PMID 16824135
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

The central question of how the immune system responds in a qualitatively and quantitatively better way upon re-exposure to a pathogen is largely unanswered. Both the increased frequency of antigen-specific memory cells and the intrinsic properties that memory cells acquire after antigen experience could contribute to the faster and more robust responses seen after repeated exposure to antigen. In the case of the memory B-cell response, it has been difficult to discern the individual contributions of these two effects. However, because of recent advances in identifying memory B cells, there is an increasing understanding of the intrinsic properties of these cells. The current insights into the unique properties of memory B cells and the progress that has been made in understanding how these affect secondary responses in both the human and the mouse systems are discussed. In addition, we compare the various advantages and disadvantages inherent in each of these systems, in terms of studying the intrinsic properties of memory B cells, and introduce the details of the system that we have developed using conventional heavy chain transgenic (Tgic) mice, which addresses some of the drawbacks of traditional memory models.

Citing Articles

Memory B cells.

Inoue T, Kurosaki T Nat Rev Immunol. 2023; 24(1):5-17.

PMID: 37400644 DOI: 10.1038/s41577-023-00897-3.


IgM and IgM memory B cells represent heterogeneous populations capable of producing class-switched antibodies and germinal center B cells upon rechallenge with P. yoelii.

Brown S, Bauer J, Lee J, Ntirandekura E, Stumhofer J J Leukoc Biol. 2022; 112(5):1115-1135.

PMID: 35657097 PMC: 9613510. DOI: 10.1002/JLB.4A0921-523R.


Humoral immune responses to infection: common mechanisms and unique strategies to combat pathogen immune evasion tactics.

Sebina I, Pepper M Curr Opin Immunol. 2018; 51:46-54.

PMID: 29477969 PMC: 6197480. DOI: 10.1016/j.coi.2018.02.001.


Beyond pan-B-cell-directed therapy - new avenues and insights into the pathogenesis of SLE.

Dorner T, Lipsky P Nat Rev Rheumatol. 2016; 12(11):645-657.

PMID: 27733759 DOI: 10.1038/nrrheum.2016.158.


Interferon-β therapy specifically reduces pathogenic memory B cells in multiple sclerosis patients by inducing a FAS-mediated apoptosis.

Rizzo F, Giacomini E, Mechelli R, Buscarinu M, Salvetti M, Severa M Immunol Cell Biol. 2016; 94(9):886-894.

PMID: 27265253 DOI: 10.1038/icb.2016.55.